title: Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation.
abstract: Despite the emerging relevance of high-density lipoprotein (HDL) in the inflammatory cascade and vascular barrier integrity, HDL levels in children undergoing cardiac surgery are unexplored. As a measure of HDL levels, the HDL-cholesterol (HDL-C) in single-ventricle patients was quantified before and after the Fontan operation, and it was determined whether relationships existed between the duration and the type of postoperative pleural effusions. The study prospectively enrolled 12 children undergoing the Fontan operation. Plasma HDL-C levels were measured before and after cardiopulmonary bypass. The outcome variables of interest were the duration and type of chest tube drainage (chylous vs. nonchylous). The Kendall rank correlation coefficient and the Wilcoxon rank sum test were used. There were 11 complete observations. The median preoperative HDL-C level for all the subjects was 30 mg/dl (range, 24-53 mg/dl), and the median postcardiopulmonary bypass level was 21 mg/dl (range, 14-46 mg/dl) (p = 0.004). There was a tendency toward a moderate inverse correlation (-0.42) between the postcardiopulmonary bypass HDL-C level and the duration of chest tube drainage, but the result was not statistically significant (p = 0.07). In the chylous effusion group, the median postcardiopulmonary bypass HDL-C tended to be lower (16 vs. 23 mg/dl; p = 0.09). After the Fontan operation, the plasma HDL-C levels in children are significantly reduced. It is reasonable to conclude that the reduction in HDL-C reflects reduced plasma levels of HDL particles, which may have pertinent implications in postoperative pleural effusions given the antiinflammatory and endothelial barrier functions of HDL.
authors.affiliation: Department of Pediatrics, Division of Pediatric Cardiology, Medical University of South Carolina, 165 Ashley Ave, MSC 915, Charleston, SC 29425, USA. chois@musc.edu
authors.forename: Sinai C
authors.initials: SC
authors.lastname: Zyblewski
authors.forename: W Scott
authors.initials: WS
authors.lastname: Argraves
authors.forename: Eric M
authors.initials: EM
authors.lastname: Graham
authors.forename: Elizabeth H
authors.initials: EH
authors.lastname: Slate
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Atz
authors.forename: Scott M
authors.initials: SM
authors.lastname: Bradley
authors.forename: Tim C
authors.initials: TC
authors.lastname: McQuinn
authors.forename: Brent A
authors.initials: BA
authors.lastname: Wilkerson
authors.forename: Shane B
authors.initials: SB
authors.lastname: Wing
authors.forename: Kelley M
authors.initials: KM
authors.lastname: Argraves
mesh_terms: D002315:Cardiopulmonary Bypass; D015505:Chest Tubes; D002648:Child; D002675:Child, Preschool; D008076:Cholesterol, HDL / Q000097:blood*; D005260:Female; D018729:Fontan Procedure; D006330:Heart Defects, Congenital / Q000097:blood* / Q000601:surgery*; D006801:Humans; D007223:Infant; D008297:Male; D010996:Pleural Effusion / Q000097:blood; D011183:Postoperative Complications / Q000097:blood; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D008076:Cholesterol, HDL